Let’s say it’s 2036, and scientists are working on a new class of drugs. Today, for instance, pharmaceutical companies use ...
Some researchers trained the immune systems of leukemia patients to help keep them in remission. And other researchers found ...
Complex sugar-protein molecules that sense external messages to help a cell grow or respond to its environment can now be ...
A 2024 U.S. national survey reported that 11.8% of males and 7.6% of females ages 12 and older met the criteria for Alcohol ...
A new study led by researchers at the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer ...
Data update from the ongoing Phase 1b/2 study of muzastotug + pembrolizumab in 3L+ MSS CRC patients remains on track for Q1 ...
Today I Found Out on MSN
How sickle cell changed human evolution
Sickle cell disease is caused by a single genetic mutation that alters the shape of red blood cells. While the condition ...
In an interview with Targeted Oncology, George Mulligan, PhD, discussed the key takeaways from analysis of the Immune Atlas ...
Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance Treg function, releases the following letter to ...
Babies of every species from mouse to human rapidly forget things that happen to them—an effect called infantile amnesia. A ...
For a long time, neuroscientists treated this forgetting as a cognitive glitch or a simple lack of brainware maturity. But a ...
A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer progression and its ability to evolve resistance to treatment, Memorial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results